Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises industrifonden in connection with pharmalink’s capital raising of sek 96 million
Mandate

Vinge advises industrifonden in connection with pharmalink’s capital raising of sek 96 million

October 08, 2013

Industrifonden and the Norwegian investment company, Investinor have invested a combined total of SEK 79 million in Pharmalink, the pharmaceuticals development company. Private investors have also contributed to the total capital raising of SEK 96 million. The funds will be used to further develop Pharmalink’s product portfolio.

Pharmalink is a pharmaceuticals company which improves and further develops existing pharmaceuticals. The company is currently conducting the Nefecon project for the treatment of inflammation of the kidneys and the Busulipo project for treatment prior to bone marrow transplantation.

Industrifonden has been a stakeholder in Pharmalink since 2004. The Norwegian investment company, Investinor is a new stakeholder.

Vinge partner Johan Larsson advised Industrifonden

Private Funds – Vinge forms new practice group for fund formation in Sweden

Historically, private equity firms have often managed their funds from abroad. More recently, there has been a clear reversal of this trend in favour of repatriating the management of funds and establishing funds as Swedish limited companies. Vinge has formed a new Private Funds practice group in order to be in a better position to advise in conjunction with Swedish fund formations.
October 03, 2022

Proposal for a European Media Freedom Act

 The European Commission has presented a proposal for new legislation which aims to protect journalists and media companies and combat disinformation.
September 26, 2022

The European Commission proposes a new Single Market Emergency Instrument

 On 19 September 2022, the Commission adopted a proposal for a new regulation on an emergency instrument for the Single Market. Following the Covid-19 pandemic and other crises in the last years, the Union has seen internal entry restrictions, unpredictable rules and supply disruptions which, according to the Commission, have highlighted that there are structural shortcomings in the EU legal framework on the Single Market. The proposed emergency instrument aims to preserve the free movement of goods, services and persons and to ensure the availability of essential goods and services in the event of future emergencies.
September 22, 2022